Summary
Quest Diagnostics, a leader in diagnostic information services, reported $7.5 billion in net revenues for 2016. The company's strategy is focused on accelerating growth and driving operational excellence. Growth is being pursued through strategic partnerships, expanding access to innovative diagnostic tests, enhancing consumer-friendliness, and supporting population health initiatives. Operational excellence efforts aim to improve efficiency and reduce costs through programs like 'Invigorate,' which has already generated over $1.1 billion in savings by the end of 2016, with a goal of $1.3 billion exiting 2017. Quest Diagnostics is actively strengthening its market position by focusing on its core diagnostic information services, divesting non-core assets, and deploying capital strategically through dividends and share repurchases. The company highlights its significant assets and capabilities, including its extensive network, advanced information technology solutions, and a strong medical and scientific staff, positioning it to capitalize on demographic trends and medical innovation. The company is navigating a dynamic healthcare landscape, emphasizing its commitment to quality, customer experience, and innovation to drive future growth.
Financial Highlights
57 data points| Revenue | $7.21B |
| Cost of Revenue | $4.62B |
| Gross Profit | $2.90B |
| SG&A Expenses | $1.38B |
| Operating Expenses | $5.94B |
| Operating Income | $1.28B |
| Interest Expense | $144.00M |
| Net Income | $645.00M |
| EPS (Basic) | $4.58 |
| EPS (Diluted) | $4.51 |
| Shares Outstanding (Basic) | 140.00M |
| Shares Outstanding (Diluted) | 142.00M |
Key Highlights
- 1Quest Diagnostics reported $7.5 billion in net revenues for the fiscal year 2016.
- 2The company's strategic focus has narrowed to two key areas: 'Accelerate Growth' and 'Drive Operational Excellence'.
- 3Growth strategies include partnerships with health plans and hospital systems, offering innovative diagnostics, improving consumer experience, and leveraging data analytics for population health.
- 4The 'Invigorate' cost excellence program achieved over $1.1 billion in run-rate savings by the end of 2016, targeting $1.3 billion by year-end 2017.
- 5Quest Diagnostics is committed to disciplined capital deployment, returning value to shareholders through dividends and share repurchases.
- 6The company is a leader in diagnostic information services with significant assets and capabilities, including an extensive national network and advanced health information technology solutions.
- 7Quest Diagnostics is actively innovating, launching over 20 new or enhanced disease area solutions in 2016, with a focus on precision medicine and advanced diagnostics.